These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 24126882)

  • 21. Practical issues regarding the use of antiretroviral therapy for HIV infection.
    Deeks SG
    West J Med; 1998 Feb; 168(2):133-9. PubMed ID: 9499754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guide to major clinical trials of antiretroviral therapy in human immunodeficiency virus-infected patients: protease inhibitors, non-nucleoside reverse transcriptase inhibitors, and nucleotide reverse transcriptase inhibitors.
    Tavel JA; Miller KD; Masur H
    Clin Infect Dis; 1999 Mar; 28(3):643-76. PubMed ID: 10194094
    [No Abstract]   [Full Text] [Related]  

  • 23. Predictors of clinically significant drug-drug interactions among patients treated with nonnucleoside reverse transcriptase inhibitor-, protease inhibitor-, and raltegravir-based antiretroviral regimens.
    Patel N; Abdelsayed S; Veve M; Miller CD
    Ann Pharmacother; 2011 Mar; 45(3):317-24. PubMed ID: 21386025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiretroviral therapy in the pregnant woman.
    Augenbraun M; Minkoff HL
    Obstet Gynecol Clin North Am; 1997 Dec; 24(4):833-54. PubMed ID: 9430170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1998 Jan; 47(RR-2):1-30. PubMed ID: 9461044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antiretroviral therapy in patients infected with HIV-1].
    Corti ME
    Medicina (B Aires); 1998; 58 Suppl 1():49-56. PubMed ID: 9674248
    [No Abstract]   [Full Text] [Related]  

  • 27. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection.
    Bozzette SA; Ake CF; Tam HK; Chang SW; Louis TA
    N Engl J Med; 2003 Feb; 348(8):702-10. PubMed ID: 12594314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cardiovascular risk factors associated with antiretroviral therapy].
    Pérez-Camacho I; Camacho A; Torre-Cisneros J; Rivero A
    Enferm Infecc Microbiol Clin; 2009 Sep; 27 Suppl 1():24-32. PubMed ID: 20172412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salvage therapy for patients failing their current antiretroviral regimen.
    Albrecht MA
    AIDS Clin Rev; 2000-2001; ():139-91. PubMed ID: 10999220
    [No Abstract]   [Full Text] [Related]  

  • 30. [Predictive factors of clinically significant drug-drug interactions among regimens based on protease inhibitors, non-nucleoside reverse transcriptase inhibitors and raltegravir].
    Cervero M; Torres R; Jusdado JJ; Pastor S; Agud JL
    Med Clin (Barc); 2016 Apr; 146(8):339-45. PubMed ID: 26971988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Virological failure and adherence to antiretroviral therapy in HIV-infected patients.
    Rodríguez-Rosado R; Jiménez-Nácher I; Soriano V; Antón P; González-Lahoz J
    AIDS; 1998 Jun; 12(9):1112-3. PubMed ID: 9662214
    [No Abstract]   [Full Text] [Related]  

  • 32. Cardiovascular disease in HIV infection.
    Sudano I; Spieker LE; Noll G; Corti R; Weber R; Lüscher TF
    Am Heart J; 2006 Jun; 151(6):1147-55. PubMed ID: 16781213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV and cardiovascular medicine.
    Prendergast BD
    Heart; 2003 Jul; 89(7):793-800. PubMed ID: 12807864
    [No Abstract]   [Full Text] [Related]  

  • 34. Highly active antiretroviral therapy failure and protease and reverse transcriptase human immunodeficiency virus type 1 gene mutations.
    Monno L; Appice A; Cavaliere R; Scarabaggio T; Angarano G
    J Infect Dis; 1999 Aug; 180(2):568-71. PubMed ID: 10395885
    [No Abstract]   [Full Text] [Related]  

  • 35. Update on treatment and prevention guidelines for HIV-related tuberculosis.
    Chaisson RE
    Hopkins HIV Rep; 1999 May; 11(3):3,10,12. PubMed ID: 11367371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination antiretroviral therapy.
    McKinney RE
    Pediatr Infect Dis J; 1998 Jun; 17(6):515-6. PubMed ID: 9655545
    [No Abstract]   [Full Text] [Related]  

  • 37. Antiretroviral therapy in older people with HIV.
    Richterman A; Sax PE
    Curr Opin HIV AIDS; 2020 Mar; 15(2):118-125. PubMed ID: 31990705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular Complications of HIV in Endemic Countries.
    Feinstein MJ; Bogorodskaya M; Bloomfield GS; Vedanthan R; Siedner MJ; Kwan GF; Longenecker CT
    Curr Cardiol Rep; 2016 Nov; 18(11):113. PubMed ID: 27730474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tuberculosis in HIV-infected patients: a comprehensive review.
    Aaron L; Saadoun D; Calatroni I; Launay O; Mémain N; Vincent V; Marchal G; Dupont B; Bouchaud O; Valeyre D; Lortholary O
    Clin Microbiol Infect; 2004 May; 10(5):388-98. PubMed ID: 15113314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of combination antiretroviral therapy in HIV-infected patients.
    Holtzer CD; Roland M
    Ann Pharmacother; 1999 Feb; 33(2):198-209. PubMed ID: 10084416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.